Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. (Q51811243)

12 April 2018

title

Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. (English)

1 reference

12 April 2018

1 reference

14

1 reference

12 April 2018

Lynn A Sleeper

5

Lynn A Sleeper

1 reference

12 April 2018

Christopher N. Bull

7

Christopher E Buller

1 reference

12 April 2018

CULPRIT-SHOCK Investigators

15

SHOCK Investigators

1 reference

12 April 2018

Timothy A Sanborn

3

Timothy A Sanborn

1 reference

12 April 2018

April M Lowe

2

April M Lowe

1 reference

12 April 2018

Jean L Boland

9

Jean Boland

1 reference

12 April 2018

Ronald G Carere

6

Ronald G Carere

1 reference

12 April 2018

Harvey D. White

4

Harvey D White

1 reference

12 April 2018

author name string

John G Webb

1

1 reference

12 April 2018

S Chiu Wong

8

1 reference

12 April 2018

Vlad Dzavik

10

1 reference

12 April 2018

Mark Porway

11

1 reference

12 April 2018

Gordon Pate

12

1 reference

12 April 2018

Geoffrey Bergman

13

1 reference

12 April 2018

language of work or name

English

0 references

publication date

1 October 2003

1 reference

12 April 2018

Journal of the American College of Cardiology

published in

1 reference

12 April 2018

volume

42

1 reference

12 April 2018

issue

8

1 reference

12 April 2018

page(s)

1380-1386

1 reference

12 April 2018

Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

One-Year Survival Following Early Revascularization for Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Prognostic value of a coronary artery jeopardy score

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

L-NMMA (a Nitric Oxide Synthase Inhibitor) is Effective in the Treatment of Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

Usefulness of coronary stenting for cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2901050-7

7 January 2021

10.1016/S0735-1097(03)01050-7

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

14563578

1 reference

12 April 2018